Surgical treatments of the nose, chin, and jawline-such as rhinoplasty and chin augmentation-remain popular in aesthetic medicine. 1,2 However, the overall numbers of such procedures are declining year on year. 1,2 A key factor underlying this trend is the increased use of nonsurgical alternatives based on minimally invasive, injectable products such as hyaluronic acid (HA) fillers. This is partly driven by patients themselves, who often present with a desire for simple procedures with immediate results, frequently arising out of peer pressure from social media and other online "influencers". 3,4 Injectables can also offer clinically meaningful advantages compared with surgery in selected individuals, including a reduced risk of complications and shorter recovery time. 5,6 HA fillers have the additional